Improvement of scleredema associated with IgA multiple myeloma after chemotherapy
- 22 March 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 20 (2) , 149-152
- https://doi.org/10.1111/j.1365-2230.1995.tb02721.x
Abstract
The presence of a monoclonal gammopathy in patients with chronic scleredema is a recently described, unusual association of unknown significance. There have been very occasional reports of multiple myeloma in such patients. We now report a patient with long-standing scleredema who developed an IgA-kappa multiple myeloma. Once chemotherapy for the myeloproliferative disorder was instituted, scleredema improved significantly, suggesting a pathogenetic link between the two conditions.Keywords
This publication has 16 references indexed in Scilit:
- Scleredema and smoldering myelomaJournal of the American Academy of Dermatology, 1992
- Scleredema adultorum associated with IgG-kappa multiple myeloma-a case report and review of the literatureClinical and Experimental Dermatology, 1988
- Scleredema of Buschke associated with multiple myelomaClinical and Experimental Dermatology, 1988
- Cardiomyopathy and multiple myeloma. Complications of scleredema adultorumArchives of internal medicine (1960), 1988
- Scleredema: A review of thirty-three casesJournal of the American Academy of Dermatology, 1984
- (45) Scleroedema adultorum with paraproteinaemiaBritish Journal of Dermatology, 1983
- Sclérœdème de Buschke et dysglobulinémie monoclonale: à propos de 3 observationsDermatology, 1983
- Monoclonal gammopathy in scleredema. Observations in three casesArchives of Dermatology, 1981
- Zervikale Dysphagie bei Scleroedema adultorum BuschkeDeutsche Medizinische Wochenschrift (1946), 1981
- Scleroedema adultorum und PlasmocytomArchives of Dermatological Research, 1974